
    
      Patients with stable coronary artery disease already taking chronic statin undergoing
      elective angioplasty are at risk for contrast-medium-induced nephropathy because there are
      specified risk factors as age more than 75 years, chronic renal insufficiency, diabetes, use
      of contrast and the lack of effective prophylaxis.
    
  